Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)

  1. Drake, M.J.
  2. MacDiarmid, S.
  3. Chapple, C.R.
  4. Esen, A.
  5. Athanasiou, S.
  6. Cambronero Santos, J.
  7. Mitcheson, D.
  8. Herschorn, S.
  9. Siddiqui, E.
  10. Huang, M.
  11. Stoelzel, M.
Aldizkaria:
International Journal of Clinical Practice

ISSN: 1742-1241,  1368-5031

Argitalpen urtea: 2017

Alea: 71

Zenbakia: 5

Mota: Artikulua

DOI: 10.1111/IJCP.12944 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus